Lipid Management
Lipid Management
Advertisement
Rob DillardLipid Management | October 14, 2024
A study found a comparable reduction in LDL-C with statins and bempedoic acid in patients with and without ASCVD.
Read More
Rob DillardLipid Management | September 20, 2024
Researchers have developed a machine learning model which can identify people who are likely to have elevated Lp(a).
Rob DillardLipid Management | September 19, 2024
Bempedoic acid treatment is similarly effective at lowering low-density lipoprotein cholesterol compared with statins.
Rob DillardADA 2024 | June 21, 2024
The use of tirzepatide in patients with obstructive sleep apnea and obesity improves both OSA severity and metabolic issues.
Rob DillardADA 2024 | June 21, 2024
Fenofibrate significantly reduces the progression of diabetic retinopathy.
CardioNerdsLipid Management | May 31, 2024
The CardioNerds and colleagues address the topic of familial hypercholesterolemia.
Rob DillardLipid Management | October 14, 2024
Women with cardiovascular disease are treated with cholesterol-lowering therapies less often than men.
Rob DillardLipid Management | September 20, 2024
Researchers assessed the impact of 4 diet programs—vegan, Mediterranean, Paleolithic, and DASH—on cardiovascular risk.
Rob DillardLipid Management | October 14, 2024
US veterans have a disproportionately high risk of atherosclerotic cardiovascular disease and a low adherence to LLT.
Rob DillardACC 2024 | September 20, 2024
Older firefighters may have more thrombotic risk factors that contribute to a higher risk of coronary heart disease.
Rob DillardLipid Management | October 14, 2024
Distinct variations of coronary artery calcium-derived coronary artery heart disease exist among retired NFL players.
Rob DillardACC 2024 | July 24, 2024
A remote, algorithm-based program is effective at helping patients achieve optimal LDL-C levels for at least 12 months.
Cynthia Miller, MDLipid Management | February 21, 2024
Cynthia Miller, MD, MPH, FACP, discusses why early Lp(a) screening may help prevent cardiovascular disease.
Rob DillardAHA 2023 | November 10, 2023
Elevated lipoprotein(a) increases the risk of major adverse cardiovascular events independent of ASCVD risk scores.
Rob DillardADA 2023 | June 25, 2023
Using tirzepatide may be an effective weight-loss option for individuals with type 2 diabetes who have obesity.
Alaa DiabCardioNerds | April 11, 2023
The following article was written by Dr. Alaa Diab as a CardioNerds Conference Scholar for ...
Patrick DalyASCO 2022 | August 30, 2023
Researchers, led by Amber Afzal, evaluated the effect of statins in patients with myelodysplastic syndromes (MDS) after ...
Rob DillardLipid Management | May 2, 2023
High cholesterol is a major risk factor for heart disease, which affects nearly 94 million Americans and is the leading ...
Rob DillardLipid Management | May 2, 2023
DocWire News recently spoke Dr. Suzanne Steinbaum, cardiologist, published author, and womens’ wellness advocate. Dr. ...
Rob DillardAtherosclerotic Disease | April 11, 2023
A literature review uncovered a significant scarcity of cost-of-illness studies on the economic impact of familial ...
Advertisement
Advertisement
Advertisement
Latest News

December 11, 2024